Peter Lloyd - Publications, H-index & Citations

Peter Lloyd

Procter & Gamble

32H指数

67论文数

4.1K被引数

收录论文 23

发表时间

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2025-12-01

OAAI

Singh, Dave; Brickman, Chaim M.; Lloyd, Peter; Kalra, Ashish; Biswas, Subhabrata; Sinha, Arkadeep; Mulvanny, Alex; Sivapalasingam, Sumathi; Becker, Oren M.; Deykin, Aaron

32-week data from a multiple ascending-dose study with verekitug, a novel antibody to the human TSLP receptor (TSLPR), in adults with asthma

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-30

PREAI

Deykin, Aaron; Brinkman, Chaim M.; Lloyd, Peter; Nestorov, Ivan; Kalra, Ashish; Biswas, Subhabrata; Sinha, Arkadeep; Sivapalasingam, Sumathi; Becker, Oren; Singh, Dave

Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-01-20

OAAI

Merchant, Rosemina; Galligan, Carole; Munegowda, Manjunatha Ankathatti; Pearce, L. Bruce; Lloyd, Peter; Smith, Paul; Merchant, Fahar; To, Minh D.

MDNA11 is a long-acting 'beta-only' IL-2 agonist that demonstrates a safe and durable anti-tumor immune response

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-12-01

PREAI

To, Minh D.; Merchant, Fahar; Muhsin, Ma'an; Galligan, Carole; Pearce, L. Bruce; Lloyd, Peter; Merchant, Rosemina

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

VACCINES

IF3.4

2021-05-18

OAAI

Harris, Paul E.; Brasel, Trevor; Massey, Christopher; Herst, C. V.; Burkholz, Scott; Lloyd, Peter; Blankenberg, Tikoes; Bey, Thomas M.; Carback, Richard; Hodge, Thomas; Ciotlos, Serban; Wang, Lu; Comer, Jason E.; Rubsamen, Reid M.

Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4

MABS

IF7.3

2019-08-23

OAAI

Griffiths, Katherine; Binder, Uli; McDowell, William; Tommasi, Rita; Frigerio, Mark; Darby, William G.; Hosking, Chris G.; Renaud, Lionel; Machacek, Matthias; Lloyd, Peter; Skerra, Arne; Foley, Michael

Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2016-11-22

PREAI

Reich, K.; Blauvelt, A.; Armstrong, A.; Langley, R. G.; Fox, T.; Huang, J.; Papavassilis, C.; Liang, E.; Lloyd, P.; Bruin, G.

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys

MABS

IF7.3

2015-07-31

OAAI

Dudal, S.; Subramanian, K.; Flandre, T.; Law, W. S.; Lowe, P. J.; Skerjanec, A.; Genin, J-C; Duval, M.; Piequet, A.; Cordier, A.; Jarai, G.; Van Heeke, G.; Taplin, S.; Krantz, C.; Jones, S.; Warren, A. P.; Brennan, F. R.; Sims, J.; Lloyd, P.

Pharmacokinetics of serelaxin in patients with hepatic impairment: a single-dose, open-label, parallel group study

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2015-05-22

OAAI

Kobalava, Zhanna; Villevalde, Svetlana; Kotovskaya, Yulia; Hinrichsen, Holger; Petersen-Sylla, Marc; Zaehringer, Andreas; Pang, Yinuo; Rajman, Iris; Canadi, Jasna; Dahlke, Marion; Lloyd, Peter; Halabi, Atef

Impact of climate change and population growth on a risk assessment for endocrine disruption in fish due to steroid estrogens in England and Wales

ENVIRONMENTAL POLLUTION

IF7.3

2015-02-01

OAAI

Keller, V. D. J.; Lloyd, P.; Terry, J. A.; Williams, R. J.

Ethnic sensitivity assessment - pharmacokinetic comparability between Japanese and non-Japanese healthy subjects on selected mAbs

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2014-12-18

PREAI

Matsushima, Soichiro; Huang, Yue; Suzuki, Hikoe; Nishino, Junichi; Lloyd, Peter

Determination of cyclophosphamide and ifosfamide in sewage effluent by stable isotope-dilution liquid chromatography-tandem mass spectrometry

JOURNAL OF CHROMATOGRAPHY A

IF4

2011-11-01

PREAI

Llewellyn, N.; Lloyd, P.; Juergens, M. D.; Johnson, A. C.

Potency values from the local lymph node assay: Application to classification, labelling and risk assessment 来自局部淋巴结测定的效力值: 在分类，标记和风险评估中的应用

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2010-02-01

PREAI

Loveless, S. E.; Api, A. -M.; Crevel, R. W. R.; Debruyne, E.; Gamer, A.; Jowsey, I. R.; Kern, P.; Kimber, I.; Lea, L.; Lloyd, P.; Mehmood, Z.; Steiling, W.; Veenstra, G.; Woolhiser, M.; Hennes, C.

The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2009-12-01

PREAI

Muller, Patrick Y.; Milton, Mark; Lloyd, Peter; Sims, Jennifer; Brennan, Frank R.

T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans

CLINICAL AND EXPERIMENTAL ALLERGY

IF5.2

2009-06-05

PREAI

Spazierer, D.; Skvara, H.; Dawid, M.; Fallahi, N.; Gruber, K.; Rose, K.; Lloyd, P.; Heuerding, S.; Stingl, G.; Jung, T.

Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2006-11-01

PREAI

Rabinowitz, Joshua D.; Lloyd, Peter M.; Munzar, Patrik; Myers, Daniel J.; Cross, Steve; Damani, Ramesh; Quintana, Reynaldo; Spyker, Daniel A.; Soni, Pravin; Cassella, James V.

Fast onset medications through thermally generated aerosols

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2004-05-01

PREAI

Rabinowitz, JD; Wensley, M; Lloyd, P; Myers, D; Shen, W; Lu, A; Hodges, C; Hale, R; Mufson, D; Zaffaroni, A

Lack or pharmacokinetic interaction between valsartan and indomethacin

JOURNAL OF HYPERTENSION

IF4.1

2000-06-01

PREAI

Lloyd, P; Prasad, P; Mueller, P